Mainz Biomed NV (FRA:4TO) ROE % Adjusted to Book Value : 0.00% (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Mainz Biomed NV ROE % Adjusted to Book Value?

Mainz Biomed NV's ROE % for the quarter that ended in Jun. 2024 was 0.00%. Mainz Biomed NV's PB Ratio for the quarter that ended in Jun. 2024 was N/A. Mainz Biomed NV's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was N/A.

Mainz Biomed NV ROE % Adjusted to Book Value Historical Data

The historical data trend for Mainz Biomed NV's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mainz Biomed NV ROE % Adjusted to Book Value Chart

Mainz Biomed NV Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

-30.31

-37.11

-41.01

Mainz Biomed NV Quarterly Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial									-23.12	-31.32	-39.62	-84.79	-

Competitive Comparison of Mainz Biomed NV's ROE % Adjusted to Book Value

For the Diagnostics & Research subindustry, Mainz Biomed NV's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mainz Biomed NV's ROE % Adjusted to Book Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Mainz Biomed NV's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Mainz Biomed NV's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Mainz Biomed NV ROE % Adjusted to Book Value Calculation

Mainz Biomed NV's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-296.12%	/	7.22
	=	-41.01%

Mainz Biomed NV's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Mainz Biomed NV ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Mainz Biomed NV's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Mainz Biomed NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Mainz Biomed NV (FRA:4TO) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

MYNZ:USA

Address

Robert Koch Strasse 5, Sirius Gutenberg Park, Mainz, RP, DEU, 55129

Website

https://www.mainzbiomed.com

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.

Mainz Biomed NV Headlines

No Headlines